Information de reference pour ce titreAccession Number: | 01434664-201610000-00004.
|
Author: | Bode, Lars; Contractor, Nikhat; Barile, Daniela; Pohl, Nicola; Prudden, Anthony R.; Boons, Geert-Jan; Jin, Yong-Su; Jennewein, Stefan
|
Institution: | L. Bode is with the Department of Pediatrics, Mother Milk Infant Center of Research Excellence (MoMI CoRE), University of California, San Diego, La Jolla, California, USA. N. Contractor is with Metagenics, Inc, Gig Harbor, Washington, USA. D. Barile is with the Department of Food Science and Technology, University of California, Davis, Davis, California, USA. N. Pohl is with the Department of Chemistry, Indiana University, Bloomington, Indiana, USA. A.R. Prudden and G.-J. Boons are with the Department of Chemistry and the Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA. Y.-S. Jin is with the Department of Food Science and Human Nutrition, Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. S. Jennewein is with Jennewein Biotechnologie GmbH, Rheinbreitbach, Rhineland Palatinate, Germany.
|
Title: | |
Source: | Nutrition Reviews. 74(10):635-644, October 2016.
|
Abstract: | Human milk oligosaccharides (HMOs) are complex sugars highly abundant in human milk but currently not present in infant formula. Rapidly accumulating evidence from in vitro and in vivo studies, combined with epidemiological associations and correlations, suggests that HMOs benefit infants through multiple mechanisms and in a variety of clinical contexts. Until recently, however, research on HMOs has been limited by an insufficient availability of HMOs. Most HMOs are found uniquely in human milk, and thus far it has been prohibitively tedious and expensive to isolate and synthesize them. This article reviews new strategies to overcome this lack of availability by generating HMOs through chemoenzymatic synthesis, microbial metabolic engineering, and isolation from human donor milk or dairy streams. Each approach has its advantages and comes with its own challenges, but combining the different methods and acknowledging their limitations creates new opportunities for research and application with the goal of improving maternal and infant health.
(C) Copyright Oxford University Press 2016.
|
Author Keywords: | bioengineering; carbohydrates; human milk oligosaccharides; milk; pediatrics; synthesis.
|
References: | 1. Kunz C. Historical aspects of human milk oligosaccharides. Adv Nutr. 2012;3:430S-439S.
2. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012;22:1147-1162.
3. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:731-747.
4. Coppa GV, Pierani P, Zampini L, et al.. Oligosaccharides in human milk during different phases of lactation. Acta Paediatr. 1999;88:89-94.
5. Gabrielli O, Zampini L, Galeazzi T, et al.. Preterm milk oligosaccharides during the first month of lactation. Pediatrics. 2011;128:e1520-e1531.
6. Newburg DS, Shen Z, Warren CD. Quantitative analysis of human milk oligosaccharides by capillary electrophoresis. Adv Exp Med Biol. 2000;478:381-382.
7. Chaturvedi P, Warren CD, Altaye M, et al.. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology. 2001;11:365-372.
8. Davidson B, Meinzen-Derr JK, Wagner CL, et al.. Fucosylated oligosaccharides in human milk in relation to gestational age and stage of lactation. Adv Exp Med Biol. 2004;554:427-430.
9. Morrow AL, Ruiz-Palacios GM, Altaye M, et al.. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr. 2004;145:297-303.
10. Kuhn L, Kim HY, Hsiao L, et al.. Oligosaccharide composition of breast milk influences survival of uninfected children born to HIV-infected mothers in Lusaka, Zambia. J Nutr. 2015;145:66-72.
11. Alderete TL, Autran C, Brekke BE, et al.. Associations between human milk oligosaccharides and infant body composition in the first 6 mo of life. Am J Clin Nutr. 2015;102:1381-1388.
12. Charbonneau MR, O'Donnell D, Blanton LV, et al.. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell. 2016;164:859-871.
13. Urashima T, Asakuma S, Leo F, et al.. The predominance of type I oligosaccharides is a feature specific to human breast milk. Adv Nutr. 2012;3:473S-482S.
14. Urashima T, Saito T, Nakamura T, et al.. Oligosaccharides of milk and colostrum in non-human mammals. Glycoconj J. 2001;18:357-371.
15. Goto K, Fukuda K, Senda A, et al.. Chemical characterization of oligosaccharides in the milk of six species of New and Old World monkeys. Glycoconj J. 2010;27:703-715.
16. Obermeier S, Rudloff S, Pohlentz G, et al.. Secretion of 13C-labelled oligosaccharides into human milk and infant's urine after an oral [13C]galactose load. Isotopes Environ Health Stud. 1999;35:119-125.
17. Dotz V, Rudloff S, Blank D, et al.. 13C-labeled oligosaccharides in breastfed infants' urine: individual-, structure- and time-dependent differences in the excretion. Glycobiology. 2014;24:185-194.
18. Goehring KC, Kennedy AD, Prieto PA, et al.. Direct evidence for the presence of human milk oligosaccharides in the circulation of breastfed infants. PLoS One. 2014;9:e101692. doi:10.1371/journal.pone.0101692.
19. Jantscher-Krenn E, Marx C, Bode L. Human milk oligosaccharides are differentially metabolised in neonatal rats. Br J Nutr. 2013;110:640-650.
20. Fransen CT, Van Laere KM, van Wijk AA, et al.. [alpha]-D-Glcp-(1[left right arrow]1)-[beta]-D-Galp-containing oligosaccharides, novel products from lactose by the action of [beta]-galactosidase. Carbohydr Res. 1998;314:101-114.
21. Roberfroid MB. Introducing inulin-type fructans. Br J Nutr. 2005;93(suppl 1):S13-S25.
22. Marino K, Lane JA, Abrahams JL, et al.. Method for milk oligosaccharide profiling by 2-aminobenzamide labelling and hydrophilic interaction chromatography. Glycobiology. 2011;21:1317-1330.
23. Sundekilde UK, Barile D, Meyrand M, et al.. Natural variability in bovine milk oligosaccharides from Danish Jersey and Holstein-Friesian breeds. J Agric Food Chem. 2012;60:6188-6196.
24. Aldredge DL, Geronimo MR, Hua S, et al.. Annotation and structural elucidation of bovine milk oligosaccharides and determination of novel fucosylated structures. Glycobiology. 2013;23:664-676.
25. Global Whey Protein Market - Growth, Trends And Forecast (2015-2020). Mordor Intelligence website. http://www.mordorintelligence.co...- ouverture dans une nouvelle fenêtre. Published September 2015. Accessed September 7, 2015.
26. Barile D, Tao N, Lebrilla CB, et al.. Permeate from cheese whey ultrafiltration is a source of milk oligosaccharides. Int Dairy J. 2009;19:524-530.
27. Thum C, Cookson A, McNabb WC, et al.. Composition and enrichment of caprine milk oligosaccharides from New Zealand Saanen goat cheese whey. J Food Compost Anal 2015;42:30-37.
28. Ganesh NV, Fujikawa K, Tan YH, et al.. HPLC-assisted automated oligosaccharide synthesis. Org Lett. 2012;14:3036-3039.
29. Nokami T, Hayashi R, Saigusa Y, et al.. Automated solution-phase synthesis of oligosaccharides via iterative electrochemical assembly of thioglycosides. Org Lett. 2013;15:4520-4523.
30. Plante OJ, Palmacci ER, Seeberger PH. Automated solid-phase synthesis of oligosaccharides. Science. 2001;291:1523-1527.
31. Tang SL, Pohl NL. Automated solution-phase synthesis of [beta]-1,4-mannuronate and [beta]-1,4-mannan. Org Lett. 2015;17:2642-2645.
32. Hsu CH, Hung SC, Wu CY, et al.. Toward automated oligosaccharide synthesis. Angew Chem Int Ed Engl. 2011;50:11872-11923.
33. Furuike T, Yamada K, Ohta T, et al.. An efficient synthesis of a biantennary sialooligosaccharide analog using a 1,6-anhydro-[beta]-lactose derivative as a key synthetic block. Tetrahedron. 2003;59:5105-5113.
34. Fair RJ, Hahm HS, Seeberger PH. Combination of automated solid-phase and enzymatic oligosaccharide synthesis provides access to [alpha](2,3)-sialylated glycans. Chem Commun. 2015;51:6183-6185.
35. Sugiarto G, Lau K, Li Y, et al.. Decreasing the sialidase activity of multifunctional Pasteurella multocida [alpha]2-3-sialyltransferase 1 (PmST1) by site-directed mutagenesis. Mol Biosys. 2011;7:3021-3027.
36. Yao W, Yan J, Chen X, et al.. Chemoenzymatic synthesis of lacto-N-tetrasaccharide and sialyl lacto-N-tetrasaccharides. Carbohydrate Res. 2015;401:5-10.
37. Yu H, Thon V, Lau K, et al.. Highly efficient chemoenzymatic synthesis of [beta]1-3-linked galactosides. Chem Commun. 2010;46:7507-7509.
38. Chen C, Zhang Y, Xue M, et al.. Sequential one-pot multienzyme (OPME) synthesis of lacto-N-neotetraose and its sialyl and fucosyl derivatives. Chem Commun. 2015;51:7689-7692.
39. Kajihara Y, Yamamoto T, Nagae H, et al.. Novel [alpha]-2,6-sialyltransferase: transfer of sialic acid to fucosyl and sialyl trisaccharides. J Org Chem. 1996;61:8632-8635.
40. Prudden AR, Chinoy ZS, Wolfert MA, et al.. A multifunctional anomeric linker for the chemoenzymatic synthesis of complex oligosaccharides. Chem Commun (Cambridge). 2014;50:7132-7135.
41. Baumgartner F, Seitz L, Sprenger GA, et al.. Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2'-fucosyllactose. Microb Cell Fact. 2013;12:40. doi:10.1186/1475-2859-12-40.
42. Chin YW, Kim JY, Lee WH, et al.. Enhanced production of 2'-fucosyllactose in engineered Escherichia coli BL21star(DE3) by modulation of lactose metabolism and fucosyltransferase. J Biotechnol. 2015;210:107-115.
43. Lee WH, Pathanibul P, Quarterman J, et al.. Whole cell biosynthesis of a functional oligosaccharide, 2'-fucosyllactose, using engineered Escherichia coli. Microb Cell Fact. 2012;11:48. doi:10.1186/1475-2859-11-48.
44. Tonetti M, Sturla L, Bisso A, et al.. Synthesis of GDP-L-fucose by the human FX protein. J Biol Chem. 1996;271:27274-27279.
45. Stevenson G, Andrianopoulos K, Hobbs M, et al.. Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid. J Bacteriol. 1996;178:4885-4893.
46. Becker DJ, Lowe JB. Fucose: biosynthesis and biological function in mammals. Glycobiology. 2003;13:41R-53R.
47. Engels L, Elling L. WbgL: a novel bacterial [alpha]1,2-fucosyltransferase for the synthesis of 2'-fucosyllactose. Glycobiology. 2014;24:170-178.
48. Shao J, Li M, Jia Q, et al.. Sequence of Escherichia coli O128 antigen biosynthesis cluster and functional identification of an [alpha]-1,2-fucosyltransferase. FEBS Lett. 2003;553:99-103.
49. Drouillard S, Mine T, Kajiwara H, et al.. Efficient synthesis of 6'-sialyllactose, 6,6'-disialyllactose, and 6'-KDO-lactose by metabolically engineered E. coli expressing a multifunctional sialyltransferase from the Photobacterium sp. JT-ISH-224. Carbohydrate Res. 2010;345:1394-1399.
50. Baumgartner F, Conrad J, Sprenger GA, et al.. Synthesis of the human milk oligosaccharide lacto-N-tetraose in metabolically engineered, plasmid-free E. coli. Chembiochem 2014;15:1896-1900.
51. Baumgartner F, Sprenger GA, Albermann C. Galactose-limited fed-batch cultivation of Escherichia coli for the production of lacto-N-tetraose. Enzyme Microbial Technol. 2015;75-76:37-43.
52. Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346:1258096. doi:10.1126/science.1258096.
53. Jennewein S, Helfrich M, inventors; Jennewein Biotechnologie Gmbh, assignee. Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation. 2015. European patent application PCT/EP2014/079212. July 23, 2015.
54. Jennewein S, inventor; Jennewein Biotechnologie Gmbh, assignee. Process for purification of a neutral human milk oligosaccharide using simulated moving bed chromatography. 2015. European patent application PCT/EP2014/071145. April 9, 2015.
55. Dekany G, Agoston K, Bajza I, et al., inventors; Glycom A/S, assignee. Synthesis of 2'-fucosyllactose. 2015. European patent application PCT/EP2010/054607. October 14, 2010.
56. Bajza I, Dekany G, Agoston K, et al., inventors; Glycom, A/S, assignee. A method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnT) containing N-acetyllactosamine. 2011. European patent application PCT/DK2011/050053. August 25, 2011.
57. Marriage BJ, Buck RH, Goehring KC, et al.. Infants fed a lower calorie formula with 2'FL show growth and 2'FL uptake like breast-fed infants. J Pediatr Gastroenterol Nutr. 2015;61:649-658.
58. Scott KP, Gratz SW, Sheridan PO, et al.. The influence of diet on the gut microbiota. Pharmacol Res. 2013;69:52-60.
|
Language: | English.
|
Document Type: | Special Articles.
|
Journal Subset: | Life Sciences.
|
ISSN: | 0029-6643
|
DOI Number: | https://dx.doi.org/10.1093/nutri...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|